Students and alumni of National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad have raised concerns over the potential termination of the MBA (Pharma) programme at the institution, echoing similar apprehensions about its discontinuation at NIPER Ahmadabad.

Sandeep Batra, an alumni of NIPER Hyderabad, lauds the MBA (Pharm) programme for its stellar reputation over the past decade. Renowned for producing highly skilled professionals, the programme boasts a remarkable 100% placement record, with top recruiters offering lucrative packages of up to Rs 28 lakh PA.

Expressing dismay, Batra highlights the adverse impact on enrolled students should the pharmaceutical management department be dissolved and the Pharma MBA course terminated. "We are deeply concerned about the recent decision to discontinue the MBA (Pharm) programme. The students earnestly urge the institute to reconsider this move and reinstate the programme for the upcoming NIPER JEE 2024," he emphasises.

Echoing these sentiments, current students underscore the invaluable benefits of the programme. They stress its role as a revenue generator for the institution, citing its minimal resource consumption and substantial annual revenue from fees.

Moreover, the programme's affordability, with Rs 5 lakhs tuition fee for a two-year course, makes it accessible to students from diverse socio-economic backgrounds.

The MBA (Pharm) programme is lauded for fostering industry collaboration and consultancy, enabling students to actively contribute to the pharmaceutical sector through internships, research projects, and consultancy work. Furthermore, the program's holistic approach to student development, exemplified by initiatives like Market Mayhem and Bio-Asia, enhances students' skills and bolsters NIPER's visibility.